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Control of integrin-mediated adhesion and mi-
gration by chemokines plays a critical role in B
cell development, differentiation, and function;
however, the underlying signaling mechanisms
are poorly defined. Here we show that the che-
mokineSDF-1 inducedactivation ofBruton’s ty-
rosine kinase (Btk) and that integrin-mediated
adhesion and migration in response to SDF-1
or CXCL13, as well as in vivo homing to lym-
phoid organs, was impaired in Btk-deficient
(pre-)B cells. Furthermore, SDF-1 induced tyro-
sine phosphorylation of Phospholipase Cg2
(PLCg2), which, unlike activation of the migra-
tion regulatory GTPases Rac or Rap1, was
mediated by Btk. PLCg2-deficient B cells also
exhibited impaired SDF-1-controlled migration.
These results reveal that Btk and PLCg2 medi-
ate chemokine-controlled migration, thereby
providing insights into the control of B cell ho-
meostasis, trafficking, and function, as well as
into the pathogenesis of the immunodeficiency
disease X-linked agammaglobulinemia (XLA).
INTRODUCTION
Integrin-mediated cell adhesion and migration play a criti-
cal role in a wide variety of processes underlying proper
organization and function of the immune system, including
B cell development and differentiation. During early B cell
development, the consecutive generation of pro-, pre-,
and immature B cells requires their retention in definedmi-
croenvironments in the bone marrow (BM), which is con-
trolled by interactions of integrin a4b1 with fibronectin
(FN) in the extracellular matrix (ECM) and with vascular
cell adhesion molecule-1 (VCAM-1)-expressing BM stro-mal cells (Arroyo et al., 1999; Leuker et al., 2001; Rose
et al., 2002; Tokoyoda et al., 2004). In mature B cells,
integrins a4b1 and leukocyte function-associated anti-
gen-1 (LFA-1) mediate high endothelial venule (HEV) at-
tachment and transendothelial migration required for
recirculation and homing, and they control cell compart-
mentalization in peripheral lymphoid tissue (Cyster, 2003,
2005; Koni et al., 2001; Miyasaka and Tanaka, 2004; Rose
et al., 2002). Integrins a4b1 and LFA-1 also play a key role
in the T cell-dependent humoral immune response, being
involved in migration of naive B cells into B cell follicles
and in the interaction of germinal center (GC) B cells
with antigen-presenting follicular dendritic cells (FDCs)
during antigen-specific B cell differentiation (Brakebusch
et al., 2002; Koopman et al., 1991, 1994; Leuker et al.,
2001; Rose et al., 2002; Spaargaren et al., 2003).
Chemokines play a prominent role in controlling integ-
rin-mediated adhesion and migration (Kinashi, 2005; Lau-
danna et al., 2002). As such, the so-called homeostatic
chemokines SDF-1 (CXCL12) and CXCL13 (BLC or
BCA-1) and their respective G protein-coupled receptors
CXCR4 and CXCR5 play a major role in B cell homeosta-
sis, trafficking, and function (Campbell et al., 2003; Cyster,
2003, 2005; Miyasaka and Tanaka, 2004). CXCR4 is ex-
pressed by all B cell subsets (Bowman et al., 2000), and
SDF-1 is highly expressed by stromal cells in the BM
and GCs, by reticulum cells aligning the GCs, and in the
splenic red pulp and lymph node medullary cords, and it
is present on HEV in lymph nodes and Peyer’s patches (Al-
len et al., 2004; Cyster, 2003, 2005; Okada et al., 2002).
SDF-1-CXCR4 signaling plays a critical role in a variety
of processes underlying proper B cell development and
function, including development and retention of precur-
sor B cells in the BM, homing of mature B cells to second-
ary lymphoid organs, trafficking and homing of plasma
cells to BM, GC organization, and T-independent humoral
immune responses (Allen et al., 2004; Cyster, 2003, 2005;
Ma et al., 1999; Nagasawa et al., 1996; Nie et al., 2004;
Okada et al., 2002; Tokoyoda et al., 2004). CXCR5 is
mainly expressed by mature B cells (Bowman et al.,Immunity 26, 93–104, January 2007 ª2007 Elsevier Inc. 93
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Btk and PLCg2 Regulate B Cell MigrationFigure 1. SDF-1 and CXCL13 Induce Integrin-Mediated B Cell Migration on VCAM-1
(A–E) Mouse pre-B cells (A), mouse splenic B cells (B), human tonsillar B cells (C), Namalwa cells (D), and DT40 cells (E) were allowed to migrate in the
absence (C) or presence of 100 ng/ml SDF-1 (SDF-1) or 500 ng/ml CXCL13 in transwells that were either uncoated or coated with 1 mg/ml VCAM-1, as
indicated. The bars represent the means ± SD of a representative experiment (C), or of 6 (A, B, and D) or 14 (E) independent experiments, each as-
sayed in triplicate, and presented as percent migration of total cells.
(F) Namalwa cells were preincubated for 1 hr at 4Cwithmediumalone (C), 10 mg/ml of an IgG1 isotype control (IgG1), or antibody Act-1 blocking a4b7
(Act-1), HP2/1 blocking a4b1 (HP2/1), or antibody TS2/16 activating integrin a4b1 (TS2/16). Subsequently, cells were allowed tomigrate for 2 hr in the
absence (C) or presence of 100 ng/ml SDF-1 (SDF-1) in transwells that were either uncoated or coated with 1 mg/ml VCAM-1, as indicated.
(G) DT40 cells were preincubated for 1 hr at 4C with medium alone (C), or 10 mg/ml of an IgG2b isotype control (IgG2b) or antibody CSAT against
integrin subunit b1 (CSAT). Subsequently, cells were allowed to migrate for 2 hr in the absence (C) or presence of 100 ng/ml SDF-1 (SDF-1) in trans-
wells that were either uncoated or coated with 1 mg/ml VCAM-1, as indicated.
(F and G) The migration was normalized to 100% for the cells not pretreated with antibody allowed to migrate in the presence of SDF-1 in transwells
coatedwith 1 mg/ml VCAM-1. The bars represent themeans ± SD of an experiment representative of three independent experiments, each performed
in triplicate.2000), and CXCL13 is produced in follicles and is present
on HEV of lymph nodes and Peyer’s patches (Miyasaka
and Tanaka, 2004). CXCL13-CXCR5 signaling is required
for migration of naive B cells into follicles and for GC orga-
nization (Allen et al., 2004; Ansel et al., 2000; Campbell
et al., 2003; Cyster, 2005; Forster et al., 1996; Okada
et al., 2002).
Despite the important role of chemokine-controlled
integrin-mediated migration in B cell development and
function as well as in the pathogenesis of B cell malignan-
cies and chronic inflammatory or autoimmune diseases,
the underlying signal transduction mechanisms are as
yet poorly defined (Kinashi, 2005; Laudanna et al., 2002).
Interestingly, many of the B cell defects in mice deficient
in SDF-1-CXCR4, CXCL13-CXCR5, VCAM-1, or a4 integ-
rin, such as impaired development and retention of B cell
precursors in the BM and impaired B cell differentiation
and immune responses (Allen et al., 2004; Ansel et al.,
2000; Arroyo et al., 1999; Forster et al., 1996; Leuker94 Immunity 26, 93–104, January 2007 ª2007 Elsevier Inc.et al., 2001; Ma et al., 1999; Nagasawa et al., 1996; Nie
et al., 2004; Okada et al., 2002), are similar to the defects
observed in the immunodeficiency diseases X-linked im-
munodeficiency (Xid) in mice and XLA in men, caused by
loss-of-function germline mutations in the cytoplasmic
tyrosine kinase Btk (Cariappa et al., 1999; Conley et al.,
2005; Ellmeier et al., 2000; Hendriks et al., 1996; Khan
et al., 1995; Middendorp et al., 2002; Nomura et al.,
2000). Combining this notion with our recent finding that
Btk is required for the control of integrin-mediated adhe-
sion by the B cell antigen receptor (BCR) (Spaargaren
et al., 2003), we hypothesized that Btk may be involved
in the signaling mechanism underlying chemokine-con-
trolled integrin-mediatedmigration. Here, we demonstrate
that SDF-1- or CXCL13-controlled integrin-mediated ad-
hesion and migration, as well as in vivo homing, of pre-B
and B cells was indeed mediated by Btk. Furthermore,
Btk mediated SDF-1-induced phosphorylation of PLCg2,
and PLCg2 mediated SDF-1-controlled migration as well.
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Btk and PLCg2 Regulate B Cell MigrationFigure 2. Btk Mediates Chemokine-Controlled Migration
(A) Btk-deficient DT40 cells reconstituted with T7-tagged Btk (Btk+), Namalwa cells, and human tonsillar B cells were stimulated with SDF-1 or anti-
IgM for 2 min. Lysates were immunoprecipitated (IP) by means of anti-Btk (Btk), anti-T7 (T7), anti-phospho-Btk (P-Btk), or anti-phosphotyrosine (PY),
and the IPs were immunoblotted (IB) with anti-phospo-Btk or anti-phosphotyrosine, as indicated. As a control, the immunoprecipitates and total ly-
sates (TL) were (re-)probed with anti-Btk.
(B) Wild-type (WT) or Btk-deficient (Btk) murine pre-B cells were allowed to migrate in the absence (C) or presence of 100 ng/ml SDF-1 (SDF-1) in
transwells coated with 1 mg/ml VCAM-1 (n = 6). The bars represent the means ± SD of six independent experiments, each performed in triplicate.
(C) Wild-type (WT), Btk-deficient (Btk), or Btk-deficient DT40 cells reconstituted with Btk (Btk+) were allowed to migrate in the absence (C) or pres-
ence of 100 ng/ml SDF-1 (SDF-1) in transwells coated with 1 mg/ml VCAM-1 (n = 8). The bars represent the means ± SD of eight independent exper-
iments, each performed in triplicate.
(D) Wild-type (WT) or Btk-deficient (Btk) DT40 cells were stimulated with SDF-1 for the indicated period of time (min) and immunoblots are probed
with anti-phospho-PKB (P-PKB) and anti-phospho-MAPK (P-ERK) and reprobed with anti-ERK2, as indicated.
(E) Wild-type (WT) or Btk-deficient (Btk) murine splenic B cells were allowed to migrate in the absence (C) or presence of 500 ng/ml CXCL13 in trans-
wells coated with 1 mg/ml VCAM-1 (n = 3). The bars represent the means ± SD of three independent experiments, each performed in triplicate.This function for Btk implies that impaired chemokine-con-
trolled migration may contribute to the developmental and
functional B cell defects observed in XLA and Xid.
RESULTS
SDF-1 and CXCL13 Induce Integrin-Mediated
Migration of B Cells
To study the control of integrin-mediated B cell migration
by the chemokines SDF-1 and CXCL13, murine BM-
derived pre-B cells, murine splenic B cells, and human
tonsillar B cells were assayed for migration toward these
chemokines in a transwell system of which the membrane
was either uncoated or coated with VCAM-1 or FN. Al-
though SDF-1 strongly induced the migration of these pri-
mary B cells on uncoated membranes, migration towardSDF-1 was more pronounced (3-fold increase) on mem-
branes coated with VCAM-1 (Figures 1A–1C). Similar re-
sults were obtained for migration on FN (not shown) and
for migration of murine splenic B cells and tonsillar B cells
toward CXCL13 (Figures 1B and 1C).
VCAM-1 and FN (not shown) also enhanced migration
toward SDF-1 of the human GC B cell-like cell line Na-
malwa (Figure 1D) and the chickenDT40B cells (Figure 1E)
by approximately 3-fold. As shown in Figure 1F, the integ-
rin a4b1-blocking antibody HP2/1 and the a4b1-activating
antibody TS2/16 completely abolished VCAM-1-medi-
ated migration of Namalwa cells toward SDF-1, whereas
no effect was observed with either an isotype control
IgG1 or the integrin a4b7-blocking antibody Act-1. Fur-
thermore, antibody CSAT, directed against the chicken
integrin b1 subunit, strongly suppressed SDF-1-inducedImmunity 26, 93–104, January 2007 ª2007 Elsevier Inc. 95
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Btk and PLCg2 Regulate B Cell Migrationmigration of DT40 cells on VCAM-1 (Figure 1G). Taken to-
gether, our data demonstrate that SDF-1 and CXCL13
control integrin (a4b1)-mediated migration of primary B
cells and B cell lines.
Btk Mediates Chemokine-Controlled Migration
Becausemany of the defects observed inmice deficient in
SDF-1-CXCR4, CXCL13-CXCR5, VCAM-1, or a4 integrin
are also observed in Xid or Btk-deficient mice and XLA
patients (as elaborated in the Discussion), and because
we have recently established that Btk is required for the
control of integrin-mediated adhesion by the BCR (Spaar-
garen et al., 2003), we hypothesized that Btk might be
involved in the signaling mechanism underlying chemo-
kine-controlled integrin-mediated migration.
In support of a possible role for Btk in chemokine-con-
trolled migration, we observed SDF-1-induced tyrosine
phosphorylation of Btk in DT40 cells, Namalwa cells,
and human tonsillar B cells (Figure 2A). Phosphorylation
of Btk could be detected with either a general phosphotyr-
osine antibody or a phospho-specific antibody for the
autophosphorylation site Y223, reflecting Btk activation.
Typically, SDF-1 induced Btk phosphorylation in a fast
and transient fashion, with optimal phosphorylation being
observed between 30 s and 2 min. A similar degree of Btk
phosphorylation was observed after suboptimal duration
of BCR stimulation (i.e., 2 min) with anti-IgM (Figure 2A);
however, optimal 5 min BCR stimulation resulted in stron-
ger Btk phosphorylation (not shown).
To directly examine a possible role for Btk in SDF-
1-controlled integrin-mediated migration, we used pre-B
cells derived from Btk-deficient mice. Interestingly, as
shown in Figure 2B, Btk-deficient pre-B cells exhibited
55% reduced SDF-1-induced migration on VCAM-1 in
comparison to WT pre-B cells. Notably, surface expres-
sion of CXCR4, integrin a4 and b1 was similar on WT
and Btk-deficient pre-B cells (see Figure S1 in the Supple-
mental Data available online). In DT40 cells, Btk deficiency
also resulted in a reduction (by 45%) of SDF-1-con-
trolled migration (Figure 2C). This defect was not due to
clonal variation because it could be completely restored
by stable transfection of a Btk expression construct (Fig-
ure 2C). Furthermore, as shown in Figure 2D, whereas
SDF-1-induced activation of the MAP kinase ERK2
(MAPK1) was slightly reduced, activation of PKB (Akt)
was not affected in the Btk-deficient cells, demonstrating
that the impaired migration is not due to a general signal-
ing defect. To examine the role of Btk in the control of
B cell migration by CXCL13, we used splenic B cells, be-
cause pre-B cells and DT40 cells do not respond to
CXCL13 (not shown). As shown in Figure 2E, Btk-deficient
B cells also exhibited impaired migration on VCAM-1 to-
ward CXCL13 (by 30%). Notably, surface expression
of CXCR5 and integrin b1 was similar on WT and Btk-
deficient splenic B cells (Figure S2).
In conclusion, these data identify Btk as a component of
the SDF-1-CXCR4 signaling cascade and reveal a regula-
tory function for Btk in chemokine-controlled integrin-
mediated migration of (pre-)B cells.96 Immunity 26, 93–104, January 2007 ª2007 Elsevier Inc.SDF-1-Controlled Adhesion Is Impaired
in Btk-Deficient B Cells
Chemokine-controlled cell migration is a complex process
that involves proper coordination of cell polarity, cyto-
skeletal reorganization, and control of integrin localization
and activity. We have previously demonstrated that Btk
mediates BCR-controlled integrin-mediated adhesion of
B cells (Spaargaren et al., 2003), so we examined whether
Btk is also involved in SDF-1-controlled integrin-mediated
adhesion. A static adhesion assay showed adhesion to
VCAM-1 in the presence of SDF-1 to be reduced by
55% in the Btk-deficient DT40 cells in comparison to
the WT DT40 cells (Figure 3A). In a more physiological
assay, i.e., under flow adhesion to SDF-1-presenting
primary HUVECs (at a shear stress of 0.8 dyn/cm2), the
stimulation of adhesion by SDF-1 was completely abol-
ished in Btk-deficient cells (Figure 3B). Taken together,
these results demonstrate that Btk also mediates SDF-
1-controlled integrin-mediated adhesion, which may
underlie the impaired chemokine-controlled migration of
Btk-deficient B cells.
In Vivo Homing Is Impaired in Btk-Deficient Pre-B
and Immature B Cells
B cell homing is critically dependent upon the differential
expression and coordinated action of B cell integrins,
endothelial cell adhesion molecules, and specific che-
mokines and their cognate receptors, including SDF-
1-CXCR4 and CXCL13-CXCR5 (Campbell et al., 2003;
Cyster, 2003, 2005; Miyasaka and Tanaka, 2004). There-
fore, to study the in vivo consequence of impaired chemo-
kine-controlled adhesion and migration resulting from
Btk deficiency, we investigated the homing capacity of
pre-B and immature B cells from Btk-deficient mice ver-
sus WT mice. Given the B cell developmental arrest in
Figure 3. SDF-1-Controlled Adhesion Is Impaired in Btk-Defi-
cient B Cells
(A) Wild-type (WT) or Btk-deficient DT40 cells (Btk) were allowed to
adhere to wells coated with 1 mg/ml VCAM-1 coimmobilized with-
out (C) or with 150 ng/ml SDF-1 (SDF-1) (n = 4; each in triplicate).
(B) Wild-type (WT) or Btk-deficient DT40 cells (Btk) were perfused at
a shear stress of 0.8 dyn/cm2 over primary HUVECs overlaid with-
out (C) or with 10 ng/ml SDF-1 (SDF-1) (n = 3; each in duplicate). The
bars in (A) and (B) represent the means ± SD of the indicated number
of experiments.
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Btk and PLCg2 Regulate B Cell MigrationFigure 4. In Vivo Homing Is Impaired in Btk-Deficient Pre-B and Immature B Cells
Cells from IL-7-driven cultures of BM from wild-type (WT) or Btk-deficient (Btk) mice were labeled with CMFDA or CMTMR, mixed, and injected into
C57Bl/6 mice. After 3 hr, peripheral blood (PB), inguinal lymph nodes (ILN), axillary lymph nodes (ALN), mesenteric lymph nodes (MLN), spleen (SPL),
and bone marrow (BM) were collected and FACS analyzed.
(A) An example of the FACS analysis of the input population, peripheral blood, and BM of a representative mouse. The B220+IgM pre-B cell fractions
were gated and analyzed for the two dye-labeled populations. The percentages of labeled cells are given within the quadrants of the dot plots. The
homing ratio of Btk-deficient (Btk) versus WT B cells was corrected for the input ratio (normalized to 1).
(B) The homing ratio of Btk versus WT B220+IgM pre-B cells in the indicated tissues (n = 5; i.e., 5 Btk/WT-combinations analyzed in 10 recipient
mice, including a dye swap). p values were <0.05 for ALN, spleen, and BM, and <0.005 for ILN and MLN. The bars represent the means ± SD of the
indicated number of combinations.
(C) The homing ratio of Btk versus WT B220+IgM+ immature B cells in the indicated tissues (n = 7; i.e., 14 recipient mice). p values were <0.01 for
blood, ALN, ILN, and MLN. The bars represent the means ± SD of the indicated number of combinations.Btk-deficient mice, we used an IL-7-driven BM culture
system to obtain better developmentally matched WT
and Btk-deficient pre-B and immature B cell populations.
3 hr after adoptive transfer, lymphoid organs were col-
lected to determine the homing ratio of the Btk-deficient
B cells compared to WT cells (Figure 4A). Interestingly,
the accumulation of the Btk-deficient pre-B cells was re-
duced in axillary (by45%), inguinal (55%), and mesen-
teric (60%) lymph nodes, the spleen (25%), and in BM
(25%) (Figure 4B). Btk-deficient IgM+ immature B cells
also exhibited impaired homing to the peripheral (by
40%–45%) and mesenteric (70%) lymph nodes, but
not to the spleen or BM (Figure 4C). Consistent with a hom-
ing defect, and opposing a possible survival disadvan-
tage, elevated numbers of Btk-deficient B cells were
recovered from the peripheral blood (Figure 4). These re-
sults clearly demonstrate that Btk-deficient pre-B and im-
mature B cells suffer from an intrinsic defect in the in vivo
homing to (secondary) lymphoid organs, characteristic of
impaired chemokine-controlled migration.The Role of Lyn and Syk Tyrosine Kinases and PI3K
in SDF-1-Controlled Migration
Recent studies have revealed an important role for cyto-
plasmic tyrosine kinases in signaling byG protein-coupled
receptors, and the cytoplasmic tyrosine kinases Lyn and
Syk play a prominent role in BCR-controlled activation of
Btk (Kurosaki, 2002). Consistent with a putative similar
role for these kinases in SDF-1-induced activation of
Btk, SDF-1-controlled migration on VCAM-1 was reduced
by 50% in DT40 cells deficient in both Lyn and Syk
(Figure S3A and Supplemental Results).
Previous studies have also implicated PI3K in chemo-
kine-controlled migration (Kinashi, 2005; Laudanna
et al., 2002) and in activation of Btk (Kurosaki, 2002). How-
ever, in comparison to the reduced migration in Btk-def-
cient DT40 cells (45%) (Figure 2C), pretreatment of
DT40 or Namalwa cells with the unrelated PI3K inhibitors
Wortmannin (WM) and LY294002 (LY) caused only a minor
reduction of SDF-1-inducedmigration (20%) (FigureS4B
and Supplemental Results). Yet, the residual migration ofImmunity 26, 93–104, January 2007 ª2007 Elsevier Inc. 97
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Btk and PLCg2 Regulate B Cell MigrationFigure 5. Btk Mediates SDF-1-Induced
Phosphorylation of PLCg2 but Not Acti-
vation of Rap1 or Rac
(A) WT DT40 cells (WT) or Btk-deficient DT40
cells (Btk) were stimulated with SDF-1 for 1,
2, or 5 min, and activation of the GTPases
was determined by GTPase pull down and im-
munoblotting with anti-Rap1 (Rap-GTP) or
anti-Rac (Rac-GTP). In parallel, total lysates
were immunoblotted with anti-Rap1 (Rap) or
anti-Rac1 (Rac).
(B and C) Namalwa cells or tonsillar B cells (B),
and WT DT40 cells (WT), Btk-deficient DT40
cells (Btk), or Btk-deficient DT40 cells recon-
stituted with Btk (Btk+) (C) were stimulated with
SDF-1 or anti-IgM for 2 min. The lysates were
immunoprecipitated (IP) by means of anti-
PLCg2 (PLCg2) or anti-phosphotyrosine (PY),
and the IPs were immunoblotted (IB) with
anti-phospo-PLCg2 (P-Y1217 or P-Y759), as
indicated. As a control, the immunoprecipi-
tates and total lysates (TL) were (re-)probed
with anti-PLCg2. Phosphorylation of PKB and
ERK2 in the cell lysates was analyzed as in
Figure 2D.the Btk-deficient cells toward SDF-1 could be further re-
duced by 60% upon PI3K inhibition (Figure S4B). Taken
together, these results suggest that PI3K and Btk mediate
SDF-1-controlled migration in a parallel fashion, indepen-
dent of each other.
Btk Mediates SDF-1-Induced Phosphorylation
of PLCg2 but Not Activation of Rap1 or Rac
Next, we wished to explore which signaling molecules
may control chemokine-controlled migration downstream
of Btk. The small GTPases Rap1 and Rac have both been
implicated in SDF-1-controlled migration of B lympho-
cytes (Kinashi, 2005; McLeod et al., 2002). Indeed,
GTPase pull-down assays revealed that SDF-1 stimula-
tion of DT40 cells resulted in enhanced amounts of
GTP-bound Rap1 and Rac; however, similar Rap1 and
Rac activation was observed upon SDF-1 stimulation of
Btk-deficient DT40 cells (Figure 5A). Thus, SDF-1-induced
activation of neither Rap1 nor Rac is mediated by Btk.
Another candidate is PLCg2, which has been identified
as a direct substrate for Btk (Kurosaki, 2002). Further-
more, we have recently established an important role for
PLCg2 in BCR-controlled integrin-mediated adhesion
(Spaargaren et al., 2003). Interestingly, SDF-1 stimulation
resulted in enhanced tyrosine phosphorylation of PLCg2
in Namalwa cells, human tonsillar B cells, and DT40 cells
(Figures 5B and 5C). SDF-1-induced phosphorylation of
PLCg2 could be detected with a general phosphotyrosine
antibody as well as by phospho-specific PLCg2 anti-
bodies directed against Y1217 and the Btk substrate site
Y759. Importantly, SDF-1-induced tyrosine phosphoryla-
tion of PLCg2 was severely reduced in the Btk-deficient
DT40 cells and could be completely restored by stable98 Immunity 26, 93–104, January 2007 ª2007 Elsevier Inc.transfection of a Btk expression construct (Figure 5C).
Most likely because of higher Btk expression, PLCg2
phosphorylation was even more pronounced in these re-
constituted cells. Furthermore, SDF-1-induced phosphor-
ylation of PKB (analyzed in the same cell lysates) was not
affected by the absence of Btk (Figure 5C), thereby em-
phasizing the specificity of the defect in PLCg2 phosphor-
ylation. Thus, these data demonstrate that Btk mediates
SDF-1-induced phosphorylation of PLCg2.
PLCg2 Mediates SDF-1-Controlled Migration
To examine a possible role for PLCg2 in SDF-1-controlled
migration, we used PLCg2-deficient DT40 cells. As shown
in Figure 6A, PLCg2-deficient DT40 cells showed a reduc-
tion of SDF-1-controlled migration on VCAM-1 by 55%.
This defect could be completely restored by gene comple-
mentation with a PLCg2 expression construct (Figure 6A),
demonstrating that the impaired migration is not due to
clonal variation. Similar to Btk-deficient DT40 cells (Fig-
ure 5C), SDF-1-induced phosphorylation of PKB was not
affected, but phosphorylation of ERK2 was reduced in
PLCg2-deficient DT40 cells (Figure 6B). Interestingly,
treatment of Namalwa or DT40 cells with the PLC inhibitor
U73122 almost completely abolished SDF-1-induced
migration on VCAM-1 (Figure 6C). These data indicate
that PLCg2, together with other isoforms of PLC, plays
an important role in SDF-1-CXCR4 signaling and SDF-
1-controlled B cell migration.
DISCUSSION
Our results reveal that Btk and PLCg2 mediate chemo-
kine-controlled integrin-mediated migration. Besides
Immunity
Btk and PLCg2 Regulate B Cell MigrationFigure 6. PLCg2 Mediates SDF-1-Controlled Migration
(A) Wild-type (WT), PLCg2-deficient (PLCg2), or PLCg2-deficient DT40 cells reconstituted with PLCg2 (PLCg2+) were allowed to migrate in the ab-
sence (C) or presence of 100 ng/ml SDF-1 (SDF-1) in transwells coated with 1 mg/ml VCAM-1, as indicated (n = 6). The bars represent the means ± SD
of six independent experiments, each performed in triplicate.
(B) Activation of PKB and ERK in wild-type (WT) or PLCg2 (PLCg2)-deficient DT40 cells after stimulation with SDF-1 for the indicated period of time
(min). The blots are probed as in Figure 2D.
(C) Namalwa cells (left) or DT40 cells (right) were pretreated with 2.5 mMU73122 (U) or left untreated for 30min, and subsequently cells were allowed to
migrate in the absence (C) or presence of 100 ng/ml SDF-1 (SDF-1) in transwells coated with 1 mg/ml VCAM-1 (n = 5). The bars represent the means ±
SD of five independent experiments, each performed in triplicate.providing several answers and new insights, this study
also raises some new questions and challenges for future
studies.
How do chemokines control Btk activity? In BCR signal-
ing, the PI3K product PIP3 is implicated in membrane re-
cruitment of Btk, enabling activation of Btk by Lyn,
whereas Syk, through phosphorylation of the adaptor
BLNK (SLP-65 or BASH), facilitates activation of PLCg2
by Btk (Kurosaki, 2002). Consistent with a putative role
for these tyrosine kinases in activation of Btk and/or
PLCg2 by SDF-1, SDF-1-controlled migration was im-
paired in B cells deficient in Lyn and Syk. In contrast,
our observations suggest that PI3K does not mediate ac-
tivation of Btk by SDF-1. Yet, SDF-1-induced membrane
recruitment of a Btk-GFP fusion protein in Hela cells was
reported to be sensitive to PI3K inhibition (Nore et al.,
2000). However, supporting our results, and opposing
the general perception that activation of Btk is strictly de-
pendent upon its PI3K-mediated membrane recruitment,
BCR-controlled phosphorylation and activation of Btk
(and PLCg2) is not affected in B cells deficient in the reg-
ulatory PI3K subunit p85a or the catalytic subunit p110d,nor in primary B cells treated with LY or WM (Jou et al.,
2002; Suzuki et al., 2003). Likewise, in accordance with
the minor effect of PI3K inhibition on SDF-1-induced B
cell migration, several recent studies have challenged
the general concept that PI3K activation is indispensable
for chemokine-controlled cell migration (Nombela-Arrieta
et al., 2004; Smit et al., 2003; Ward, 2004). Nevertheless,
the residual migration of Btk-deficient cells was largely
PI3K dependent. Most likely, this involves the catalytic
p110d and adaptor p85a subunits (Figure 7), which, in
contrast to the catalytic subunit p110g, have been impli-
cated in chemokine-controlled B cell migration (Nom-
bela-Arrieta et al., 2004; Reif et al., 2004). Recently, B cells
were shown to require the scaffolding protein DOCK2 for
efficient SDF-1- and CXCL13-controlled migration and in-
tegrin-mediated adhesion to ICAM-1 and VCAM-1, re-
spectively (Kinashi, 2005; Nombela-Arrieta et al., 2004).
DOCK2, like Btk, mediates chemokine-controlled migra-
tion in a largely PI3K-independent fashion (Nombela-
Arrieta et al., 2004), so it is tempting to speculate that
DOCK2 may be involved in chemokine-induced Btk or
PLCg2 activation (Figure 7). Alternatively, by analogy toImmunity 26, 93–104, January 2007 ª2007 Elsevier Inc. 99
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may be involved. Finally, as previously established for
Ga (aq and a12) and Gb/g subunits (Bence et al., 1997;
Lowry and Huang, 2002), the membrane recruitment and
activation of Btkmay bemediated by the direct interaction
of chemokine receptor-activated G protein subunits
(Figure 7).
How do Btk and PLCg2 control chemokine-induced mi-
gration? Our results strongly indicate that Btk mediates
chemokine-controlled migration through PLCg2, which
is highly expressed in all B cell subsets (Figure 7). To our
knowledge, the only previous evidence for a possible
role for PLC-g in chemokine signaling is the observation
that SDF-1 induces tyrosine phosphorylation of PLC-g
(isotype undefined) in hematopoietic progenitor cells
(Wang et al., 2000). In addition, since SDF-1-induced mi-
gration could be completely abolished with the general
PLC inhibitor U-73122, other PLC isotypes, such as
PLCg1, which is highly expressed in pro- and pre-B cells,
or PLCb, may be involved as well (Figure 7). Similar to our
observations, CXCR3-mediated migration of T lympho-
cytes is relatively insensitive to PI3K inhibition, but can
be completely abolished by PLC inhibition (Smit et al.,
2003). The observed critical role of PLC, including
PLCg2, in chemokine-controlled migration points toward
an important downstream role for calcium- and/or DAG-
dependent signaling molecules. Likely candidates are
the classical and novel isoforms of PKC and the RasGRP
(CalDAG-GEF) family of exchange factors, which act on
different Ras family GTPases, including Ras and Rap1
(Kinashi, 2005). Indeed, Rap1 was shown to be involved
in SDF-1-induced migration of B lymphocytes (McLeod
Figure 7. The Role of Btk and PLCg2 in the Signaling Cas-
cades Underlying Chemokine-Controlled Integrin-Mediated
Migration
A schematic representation of the (putative) signaling pathways under-
lying chemokine-controlled integrin (a4b1)-mediated migration is
shown. The proteins studied and connections established in this study
are represented by the bold boxes and bold arrows, respectively. See
the Discussion section for further detail.100 Immunity 26, 93–104, January 2007 ª2007 Elsevier Inc.et al., 2002; Shimonaka et al., 2003). However, SDF-
1-induced activation of Rap1 was not impaired in Btk- or
PLCg2-deficient B cells. Similarly, activation of Rap1 by
SDF-1 is not impaired in Jurkat T cells deficient in
PLCg1, the major PLC-g isotype in T cells (Katagiri et al.,
2004). The activation of Rac, another GTPase implicated
in chemokine-controlled migration, can occur through
PI3K-dependent and PI3K-independent mechanisms
(Kinashi, 2005; Ward, 2004). Noteworthy, DOCK2 also
mediates activation of Rac (and Rap) (Nombela-Arrieta
et al., 2004; Sanui et al., 2003). However, SDF-1-induced
activation of Rac was not impaired in Btk- or PLCg2-defi-
cient B cells. Taken together, our data indicate that Btk,
Rap1, and Rac act in parallel signaling pathways in che-
mokine-controlled B cell migration (Figure 7).
What about the role of other Tec family kinases in che-
mokine-controlled migration? Several members of the
Tec family of tyrosine kinases, consisting of Tec, Btk, Itk,
Rlk, and Bmx, have previously been implicated in cyto-
skeletal reorganization, integrin-mediated adhesion, or
migration (Berg et al., 2005). In B cells, we have previously
shown that Btk mediates BCR-controlled a4b1-mediated
adhesion, which involves cytoskeletal reorganization
(Spaargaren et al., 2003). Similarly, in T cells, Itk mediates
TCR-controlled actin polymerization and activation of b1
integrins (Berg et al., 2005). Moreover, two recent studies
revealed a critical role for the Tec family kinases Itk and Rlk
in chemokine-controlled migration of T cells (Fischer et al.,
2004; Takesono et al., 2004). Furthermore, in neutrophils,
the chemotactic peptide fMLP induces the membrane re-
cruitment and activation of Tec, Btk, and Bmx (Lachance
et al., 2002), which, like the chemotactic response, can be
suppressed by the pharmacological Tec family kinase in-
hibitor LFM-A13 (Gilbert et al., 2003). Recently, LFM-A13
was also reported to inhibit SDF-1-induced B cell migra-
tion and homing, and solely based upon the use of this in-
hibitor, the authors propose a role for Btk in these pro-
cesses (Ortolano et al., 2006). We would like to
emphasize, however, that LFM-A13 is not a specific Btk
inhibitor: it is a potent inhibitor of the other Tec family ki-
nases as well (Chau et al., 2005; Fernandes et al., 2005;
Gilbert et al., 2003), and LFM-A13 is an equally efficient in-
hibitor of the nonrelated kinase JAK2 (van den Akker et al.,
2004), which has also been implicated in SDF-1-induced
lymphocyte migration (Soriano et al., 2003; Zhang et al.,
2001). Yet, combining all of the above with our current
findings, Tec family kinases appear to play an important
role in chemokine-controlled adhesion and migration, at
least in lymphocytes. Given the observed partial redun-
dancy of Btk with Tec in murine B cells (Ellmeier et al.,
2000), it would be interesting to determine whether Tec
(or another Tec family member) is responsible for the re-
sidual migration observed in Btk-deficient (pre-)B cells.
Furthermore, by analogy to the role of Btk and PLCg2 in
chemokine-controlled B cell migration, it would be inter-
esting to determine whether chemokine-controlled migra-
tion of T lymphocytes involves Itk- or Rlk-mediated phos-
phorylation and activation of PLCg1, the major PLC-g
isotype in T cells.
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demonstrates a direct role for Btk in signaling by CXCR4
and in chemokine-controlled adhesion, migration, and
homing. Interestingly, loss-of-function germline mutations
in the BTK gene give rise to the B cell immunodeficiency
disease XLA in humans and Xid in mice. XLA patients
show a severe reduction in mature B cell numbers
(>99%) (Conley et al., 2005; Nomura et al., 2000), and in
Xid- and the phenotypically identical Btk-deficient mice,
mature B cell numbers are 50% reduced (Khan et al.,
1995). The earliest role for Btk occurs during B cell devel-
opment at the progression from pre-B to immature B cells,
which is severely impaired in XLA patients and to a lesser
extent in Xid and Btk-deficient mice (Conley et al., 2005;
Hendriks et al., 1996; Middendorp et al., 2002). In XLA,
this involves a proliferation defect of the mH-chain-positive
pre-B cells (Nomura et al., 2000), and in Xid mice this in-
volves a defect in cellular maturation of pre-B cells (Mid-
dendorp et al., 2002). Furthermore, Xidmice have been re-
ported to display a defect in the retention of immature B
cells in the BM (Cariappa et al., 1999). Interestingly, a4 in-
tegrin-deficient pre-B cells also display a proliferation de-
fect (Arroyo et al., 1999), and SDF-1 was originally identi-
fied as a pre-B cell growth-stimulating factor. Moreover,
our results as well as previous studies (Bowman et al.,
2000; Tokoyoda et al., 2004) show that SDF-1 controls
a4b1-mediated adhesion and migration of pre-B and
immature B cells, and mice deficient in SDF-1-CXCR4,
VCAM-1, or a4 integrin display defects in development
and retention of precursor (pro-, pre-, and immature) B
cells in the BM (Arroyo et al., 1999; Leuker et al., 2001;
Ma et al., 1999; Nagasawa et al., 1996; Nie et al., 2004).
In the mature B cell population, Btk-deficient mice reveal
a defect in follicular entry of long-lived recirculating follicu-
lar cells, in follicle and GC formation, in T-independent im-
mune response, and a strongly reduced primary and vari-
ably affected secondary T-dependent immune response,
whereas both responses are absent in Btk/Tec double-
deficient mice (Ellmeier et al., 2000; Hendriks et al., 1996;
Khan et al., 1995; Ridderstad et al., 1996; Vinuesa et al.,
2001). Similarly, mice deficient in either SDF-1 or CXCR4
and mice deficient in either CXCL13 or CXCR5 display de-
fects inmigration of naiveBcells into follicles, GCBcellmi-
gration, andGCorganization (Allen et al., 2004; Ansel et al.,
2000; Forster et al., 1996; Okada et al., 2002), CXCR4-
deficient mice show a loss of T-independent immune re-
sponse (Nie et al., 2004), and mice lacking either VCAM-1
expression on FDCs or expression of integrin b1 in the
hematopoietic system exhibit an impaired T-dependent
immune response (Brakebusch et al., 2002; Koni et al.,
2001; Leuker et al., 2001). Thus, based upon our current
findings, impaired chemokine (SDF-1 or CXCL13)-con-
trolled adhesion and migration, required for localization
of pre-Band immatureBcells in theappropriateBMniches
and for emigration of immature B cells from the BM into
the blood and to secondary lymphoid organs, may very
well contribute to the defects in early B cell development
in XLA and Xid and to the partial defects in localization, dif-
ferentiation, and responses of mature B cells in Xid mice.In conclusion, our results demonstrate that Btk and
PLCg2 mediate chemokine-controlled B cell adhesion
andmigration, which play an important role in B cell devel-
opment and function as well as in the pathogenesis of
B cell malignancies and chronic inflammatory or autoim-
mune diseases. Furthermore, our results indicate that
impaired adhesion and migration, resulting from loss-
of-function germline mutations of BTK, may contribute to
the developmental and functional B cell defects observed
in XLA patients and Xid mice.
EXPERIMENTAL PROCEDURES
See Supplemental Experimental Procedures online for complete
methods.
Materials
The following reagents were used in this study: phosphorylation state-
specific antibodies phospho-p44/42 MAP kinase [T202/Y204], phos-
pho-Akt [S473], phospho-Btk [Y223], phospho-PLCg2 [Y759], and
phospho-PLCg2 [Y1217] (Cell Signaling Technology); phosphotyro-
sine antibodies PY20 (BD Biosciences) and 4G10 (Upstate Biotechnol-
ogy); rabbit polyclonal antibodies against ERK2 (C-14), Akt1/2 (H-136),
Btk (C20), PLCg2 (Q20 and H160) (Santa Cruz Biotechnology), and
CXCR4 (AB 1846) (Chemicon); mouse monoclonal antibodies against
T7 (Novagen), Btk (G149-11), Rap1, and Rac1 (BD Biosciences);
mouse monoclonal IgG1 antibodies HP2/1 against integrin subunit
a4 (Immunotech), Act-1 against integrin subunit b7 (kindly provided
by A. Lazarovits), TS2/16 against integrin subunit b1 (kindly provided
by F. Sanchez-Madrid), CSAT IgG2b against the chicken integrin sub-
unit b1 (DSHB, University of Iowa); rat and hamster monoclonal anti-
bodies PS/2-biotin and OXM718-FITC against mouse integrin a4 and
b1, respectively (Chemicon), and 2G8-biotin against CXCR5 (BD Bio-
sciences); anti-CD45R(B220) microbeads (Miltenyi Biotec); mouse
anti-human IgM (MH15) (Sanquin, Amsterdam, the Netherlands), goat
anti-chicken IgM (Bethyl Laboratories); anti-B220-FITC (Leinco Tech-
nologies), anti-IgM-biotin (BD Biosciences), Streptavidin-PE, Strepta-
vidin-FITC, goat anti-mouse-Biotin, goat anti-mouse-PE (Southern
BiotechnologyAssociates), Swine anti-Rabbit-FITC (DAKO), and rabbit
anti-goat-Biotin (Vector); pharmacological inhibitors PD-98059,
LY-294002, Wortmannin, U-73122 (Biomol); recombinant human
sVCAM-1,SDF-1aandBCA-1/CXCL13 (R&DSystems), humanplasma
FN, and BSA (fraction V) (Sigma); CMFDA and CMTMR (Molecular
Probes).
Isolation of Tonsillar B Cells, Murine Pre-B Cells,
and Splenic B Cells
Human tonsillar B cells, mouse splenic B cells from Btk-deficient mice
andWT littermate controls, andmouse pre-B cells (IL-7-driven primary
BM cultures of WT and Btk-deficient mice) were obtained essentially
as described (Koopman et al., 1994; Middendorp et al., 2002; Spaar-
garen et al., 2003).
Cell Migration Assay
Migration assays were performed in triplicate with transwells (Costar)
coated with 1 mg/ml sVCAM-1 or 10 mg/ml FN. The lower compartment
contained 100 ng/ml SDF-1 or 500 ng/ml CXCL13, and the cells were
applied to the upper compartment and allowed to migrate for 5 hr
(DT40 and Namalwa), 3.5 hr (tonsillar B cells), 2.5 hr (splenic B cells),
or 1 hr (pre-B cells) at 37C (39.5C for DT40), unless otherwise indi-
cated. The amount of viable migrated cells was determined by FACS
and expressed as a percentage of the input. Unless otherwise indi-
cated, the migration of nonpretreated WT cells on VCAM-1-coated
transwells in the presence of SDF-1 or CXCL13 was normalized to
100%, and the bars represent the means ± SD of at least three inde-
pendent experiments, each assayed in triplicate.Immunity 26, 93–104, January 2007 ª2007 Elsevier Inc. 101
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The static cell adhesion to VCAM-1 was assayed essentially as de-
scribed (Spaargaren et al., 2003), except that 150 ng/ml SDF-1 was
coimmobilized with 1 mg/ml VCAM-1 on the plates, the plates were
spun directly after applying the cells to the plate, and the cells were
allowed to adhere for 2 min.
The under flow cell adhesion to HUVECs was assayed essentially as
described (da Costa Martins et al., 2006). In brief, primary HUVECs
were overlaid with 10 ng/ml SDF-1 prior to perfusion, DT40 cells
were perfused at 0.8 dyn/cm2 for 5 min, and 20 randomized images re-
corded between 2 and 5 min were analyzed to determine the average
amount of adhering cells per field.
In both assays, the adhesion of WT cells in the presence SDF-1 was
normalized to 100%.
Homing Assay
Cells from IL-7-driven BM cultures of WT and Btk-deficient mice were
labeled with either CMFDA or CMTMR, mixed (1:1), and injected intra-
veneously in C57Bl/6 mice. Each WT/Btk combination was analyzed
by adoptive transfer of two recipient mice, which included a dye-swap.
After 3 hr, lymphoid organs were collected and FACS analyzed to iden-
tify pre-B and immature B cells by their B220/IgM profile and to quan-
tify dye-labeled cells. The homing ratio (Btk-deficient/WT cells) was
corrected for the input ratio (which was normalized to 1).
Immunoprecipitation and Immunoblotting
For analysis of Btk and PLCg2 tyrosine phosphorylation, cells were
stimulated with 200 ng/ml SDF-1 or 10 mg/ml anti-IgM and immunopre-
cipitated with anti-Btk (C20), anti-T7, anti-P-Btk, anti-PLCg2 (Q20), or
anti-phosphotyrosine (PY20 or 4G10). Immunoprecipitates and total
lysates were analyzed by SDS-PAGE and immunoblotting with anti-
P-Btk, anti-Btk (G149-11), anti-P-PLCg2, anti-PLCg2 (H160), or anti-
phosphotyrosine (4G10).
For analysis of ERK and PKB phosphorylation, cells were stimulated
with 100 ng/ml SDF-1 and immunoblotted with anti-phospho-MAPK
and anti-phospho-PKB, as described (Spaargaren et al., 2003).
Rac and Rap1 Activity Pull-Down Assays
Cells were stimulated with SDF-1 (100 ng/ml), and cell lysates were
prepared and used immediately for GTPase pull-down assays with
GST-RalGDS-RBD or GST-PAK-RBD fusion protein for Rap and
Rac, respectively. Bound proteins were eluted with sample buffer,
separated by 15% SDS-PAGE, and immunoblotted with anti-Rap1
or anti-Rac1.
Statistical Analysis
The unpaired two-tailed Student’s t test was used to determine the sig-
nificance of differences between means. Unless otherwise indicated,
all relevant comparisons (e.g., control versus inhibitors or WT versus
gene-deficient cells) were significantly different (p < 0.05).
Supplemental Data
Supplemental Data include four figures, Supplemental Results, and
Supplemental Experimental Procedures and can be found with this ar-
ticle online at http://www.immunity.com/cgi/content/full/26/1/93/
DC1/.
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